Freezing

S.BIOMEDICS completes brain transplant of hESC-derived dopaminergic progenitors (TED-A9) for Phase 1/2a study in patients with Parkinson’s disease

Retrieved on: 
Thursday, February 29, 2024

S.BIOMEDICS Co., Ltd. (KOSDAQ: 304360) announced that it has successfully completed the brain transplant of TED-A9 (hESC-derived dopaminergic progenitors) for Phase 1/2a study for treating Parkinson's disease.

Key Points: 
  • S.BIOMEDICS Co., Ltd. (KOSDAQ: 304360) announced that it has successfully completed the brain transplant of TED-A9 (hESC-derived dopaminergic progenitors) for Phase 1/2a study for treating Parkinson's disease.
  • The primary objective of the Phase 1/2a trial is to assess the safety and exploratory efficacy of TED-A9 transplantation for two years post-transplant.
  • “We have developed a fundamental therapeutic mechanism that directly replaces dopaminergic neurons lost in patients with Parkinson's disease.
  • TED-A9 could represent a fundamental treatment that surpasses current therapies, which only temporarily alleviate the symptoms of Parkinson’s disease,” he added.

BLUETTI Launches SwapSolar on Indiegogo, Transforming Outdoor Experience

Retrieved on: 
Wednesday, February 21, 2024

BLUETTI, a leading innovator in green energy storage solutions, announces the official launch of its ground-breaking SwapSolar ecosystem on Indiegogo on February 21 at CET 3 pm.

Key Points: 
  • BLUETTI, a leading innovator in green energy storage solutions, announces the official launch of its ground-breaking SwapSolar ecosystem on Indiegogo on February 21 at CET 3 pm.
  • Debuted at CES 2024, SwapSolar introduces the world's first LFP-powered MultiCooler portable fridge and the AC180T hot-swappable battery power station, redefining convenience and functionality for outdoor enthusiasts.
  • View the full release here: https://www.businesswire.com/news/home/20240220126870/en/
    James Ray, BLUETTI's spokesperson, captures the essence of SwapSolar: "We want users to savor the joy of outdoor life.
  • BLUETTI offers a 5-year warranty for the AC180T and a 2-year warranty for the MultiCooler.

Groundbreaking New Procedure for Azoospermic Men Involving Minimally Invasive Sperm Mapping Combined with Extended Sperm Search and Microfreeze Leads to First Pregnancy

Retrieved on: 
Thursday, March 7, 2024

NEW YORK, March 7, 2024 /PRNewswire-PRWeb/ --Maze Sexual & Reproductive Health has announced the first pregnancy worldwide as a result of a new, minimally invasive procedure. Specifically, sperm are collected via Sperm Mapping, and then searched for and, if found, frozen or used fresh using Extended Sperm Search and Microfreeze (ESSM). They can then be injected into a partner's egg. The combined procedure, called Grid Needle Sperm Extraction and MicroSearch (GN-SEM), will allow some men with no sperm in the ejaculate (azoospermia) the ability to initiate a pregnancy without surgically opening up the testicle.

Key Points: 
  • Specifically, sperm are collected via Sperm Mapping, and then searched for and, if found, frozen or used fresh using Extended Sperm Search and Microfreeze (ESSM).
  • I'm extremely proud of the fact that we have profoundly changed the way we treat azoospermic and cryptospermic men.
  • With men with cryptospermia (very very few sperm in the ejaculate) we have found and frozen sperm in almost 100% of men! ''
  • As of today, Maze has 30 babies born from sperm collected through ESSM, and 97 men whose sperm are stored.

IceCure Medical to Present at 34th Annual Oppenheimer Healthcare MedTech & Services Conference

Retrieved on: 
Thursday, March 7, 2024

CAESAREA, Israel, March 7, 2024 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced that the Company's Chief Executive Officer, Eyal Shamir, will present at the 34th Annual Oppenheimer Healthcare MedTech & Services Conference on Tuesday, March 12, 2024, at 8:00am EST.

Key Points: 
  • CAESAREA, Israel, March 7, 2024 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced that the Company's Chief Executive Officer, Eyal Shamir, will present at the 34th Annual Oppenheimer Healthcare MedTech & Services Conference on Tuesday, March 12, 2024, at 8:00am EST.
  • Investors may view the presentation at the virtual conference through the following LINK live and for 180 days following conference.
  • Mr. Shamir will provide an update on IceCure's latest developments including the Company's ICE3 breast cancer trial with its pending De Novo Classification Request with the U.S. Food and Drug Administration ("FDA") for marketing clearance of ProSense® for the treatment of patients with early-stage, low-risk breast cancer as well as ProSense®'s increasing global commercial reach and the growing body of independent research on the efficacy of cryoablation.

Announcing the Reintroduction of Uponor AquaPEX® Blue Pipe

Retrieved on: 
Tuesday, March 5, 2024

CHICAGO, March 5, 2024 /PRNewswire-PRWeb/ -- Designed to address skilled-labor challenges with a solution that offers full-color differentiation for cold-water plumbing lines, Uponor AquaPEX® Blue pipe is now available for residential and commercial domestic-water applications.

Key Points: 
  • Uponor introduced its latest solution for addressing skilled-labor challenges in plumbing—the Uponor AquaPEX® Blue pipe.
  • "Additionally, the blue pipe — like all other Uponor PEX-a piping products — can expand up to three times the outside diameter to be extremely resilient in freezing conditions."
  • Uponor AquaPEX Blue pipe is manufactured in the U.S. for fast distribution and is confidently backed by an industry-leading 25-year transferable limited warranty when used with Uponor ProPEX® rings and fittings as a complete system.
  • For more details about Uponor AquaPEX Blue as well as Uponor AquaPEX Red piping solutions, visit uponor.com .

Dr. Honig Joins Legacy as Strategic Advisor, Bringing Expertise in Male Reproductive Health and Urology

Retrieved on: 
Tuesday, March 5, 2024

NEW YORK, March 5, 2024 /PRNewswire/ -- Legacy, the leading provider of at-home sperm testing and freezing solutions in the United States, proudly announces the appointment of Dr. Honig, a distinguished Professor of Urology and Division Chief of Sexual and Reproductive Medicine at Yale University School of Medicine, as a Strategic Advisor.

Key Points: 
  • Dr. Honig's extensive expertise in male reproductive health and urology will significantly enhance Legacy's commitment to innovation in the field of male fertility care.
  • With a remarkable background in academia and clinical practice, Dr. Honig brings a wealth of experience to his new role at Legacy.
  • "The company's commitment to advancing male fertility care aligns with my passion for enhancing access to comprehensive reproductive health services.
  • In his role as a Strategic Advisor, Dr. Honig will provide valuable guidance and strategic vision to further propel Legacy's mission of revolutionizing male fertility care.

IceCure's ProSense® a Promising Alternative Treatment for Extra-Pelvis Endometriosis: Independent Study Presented at ECR 2024

Retrieved on: 
Monday, March 4, 2024

Five doctors participated in the study, including interventional radiologist and ProSense® user Prof. Julien Frandon, who has previously led hands-on training sessions with ProSense® at multiple medical conferences.

Key Points: 
  • Five doctors participated in the study, including interventional radiologist and ProSense® user Prof. Julien Frandon, who has previously led hands-on training sessions with ProSense® at multiple medical conferences.
  • The investigator-initiated single-site study enrolled 7 women, ages 30-45 years, with endometriosis in the abdominal wall and para-diaphragmatic areas.
  • One month following treatment, assessment by MRI revealed hemorrhagic signal had disappeared and necrotic changes developed.
  • We are very pleased that all patients treated in this study were relieved of their endometriosis condition and pain within as little as a month following treatment," stated IceCure CEO Eyal Shamir.

STOREDOT'S BATTERY TECHNOLOGY OFFERS EV OWNERS A WINTERPROOF CHARGING EXPERIENCE

Retrieved on: 
Monday, March 4, 2024

This means that EV drivers can recharge their vehicles even in freezing weather, while still maintaining an excellent driving range.

Key Points: 
  • This means that EV drivers can recharge their vehicles even in freezing weather, while still maintaining an excellent driving range.
  • With this technology, winter range anxiety is eliminated, providing EV drivers with a reliable and efficient solution.
  • Recent laboratory tests show StoreDot's silicon battery cells reach 80% capacity when charged at -10°C with standard charging speed.
  • StoreDot's battery cells have been tested and have shown a consistent discharge rate and an adequate driving range, even in sub-freezing conditions.

7th Annual Plunge for Elodie Set to Surpass $2.5 Million Raised for EB Research Partnership

Retrieved on: 
Thursday, February 29, 2024

WELLESLEY, Mass., Feb. 29, 2024 /PRNewswire/ -- EB Research Partnership (EBRP) announces the 7th annual Plunge For Elodie scheduled for March 10 - April 27, 2024. Since its inception, the Plunge for Elodie has evolved from a small hometown fundraiser into a global movement, inviting participants to plunge into freezing waters to raise awareness and funds for the life-threatening rare genetic skin disorder, Epidermolysis Bullosa (EB). This year marks a groundbreaking year for the Plunge for Elodie with more than 20 events worldwide. The goal is to raise $500,000 in 2024 which would help the event's fundraising total surpass $2.5M raised for life-saving EB research since 2018. 

Key Points: 
  • WELLESLEY, Mass., Feb. 29, 2024 /PRNewswire/ -- EB Research Partnership (EBRP) announces the 7th annual Plunge For Elodie scheduled for March 10 - April 27, 2024.
  • This year marks a groundbreaking year for the Plunge for Elodie with more than 20 events worldwide.
  • The goal is to raise $500,000 in 2024 which would help the event's fundraising total surpass $2.5M raised for life-saving EB research since 2018.
  • The Plunge for Elodie was created by 10 childhood friends of Elodie's mom, EBRP Board Member Emily Kubik.

Huawei Releases the High-Quality 10 Gbps Campus Network Construction White Paper Supported by WBA

Retrieved on: 
Wednesday, February 28, 2024

BARCELONA, Spain, Feb. 28, 2024 /PRNewswire/ -- During the Mobile World Congress 2024, Huawei released the High-Quality 10 Gbps Campus Network Construction White Paper supported by WBA (Wireless Broadband Alliance) at the summit themed "Huawei Intelligent Cloud-Network, Accelerating Industrial Intelligence". This white paper puts forwards the philosophy of experience-centric campus network construction; it also delves into how Huawei's High-Quality 10 Gbps CloudCampus Solution offers three types of experience upgrade — wireless, application, and Operations and Maintenance (O&M) — to accelerate enterprises' digital and intelligent journey.

Key Points: 
  • BARCELONA, Spain, Feb. 28, 2024 /PRNewswire/ -- During the Mobile World Congress 2024, Huawei released the High-Quality 10 Gbps Campus Network Construction White Paper supported by WBA (Wireless Broadband Alliance) at the summit themed "Huawei Intelligent Cloud-Network, Accelerating Industrial Intelligence".
  • This white paper puts forwards the philosophy of experience-centric campus network construction; it also delves into how Huawei's High-Quality 10 Gbps CloudCampus Solution offers three types of experience upgrade — wireless, application, and Operations and Maintenance (O&M) — to accelerate enterprises' digital and intelligent journey.
  • To keep up with these changes, campus networks need to evolve from connectivity-centric to experience-centric.
  • This white paper explores the new campus network trends and maps out the campus network evolution direction for enterprises to accelerate their digital and intelligent journey.